Suppr超能文献

荷兰分阶段实施 CRC 筛查计划后,晚期 CRC 的发病模式。

Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands.

机构信息

Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.

出版信息

Eur J Cancer. 2023 Jan;178:60-67. doi: 10.1016/j.ejca.2022.10.016. Epub 2022 Oct 26.

Abstract

BACKGROUND AND AIMS

From 2014, the Dutch colorectal cancer (CRC) faecal immunochemical testing-based screening programme was gradually rolled out by birth cohort. We evaluated changes in advanced-stage CRC incidence by timing of invitation to further strengthen the evidence for the effectiveness of CRC screening.

METHODS

Data on advanced-stage CRC incidence in the period 2010-2019 by invitation cohort were collected through the Netherlands Cancer Registry. Crude rates of advanced-stage CRC incidence and cumulative advanced-stage CRC incidence were calculated. Observed advanced-stage CRC incidence and cumulative advanced-stage CRC incidence were compared with expected advanced-stage CRC incidence and cumulative advanced-stage CRC incidence by invitation cohort using trend lines extrapolating data prior to the introduction of screening.

RESULTS

For the invitation cohort that was first invited for screening in 2014, advanced-stage CRC incidence increased before the introduction of screening from 94.1 to 124.7 per 100,000 individuals in the period 2010-2013. In 2014, the observed increase was higher than in preceding years, to 184.9 per 100,000 individuals. Hereafter, a decrease in incidence was observed to levels below expected incidence based on trends before the introduction of screening. A similar pattern was observed for invitation cohorts in subsequent years, coinciding with the first invitation to the screening programme. In 2019, the observed incidence for all invitation cohorts remained below expected incidence. The cumulative advanced-stage CRC incidence in the 2014-2016 invitation cohorts was significantly lower than the expected cumulative CRC incidence in the period 2010-2019.

CONCLUSIONS

In the period 2014-2019, an increase in advanced-stage CRC incidence was observed for all invitation cohorts first invited for screening, followed by a decrease below expected incidence, following the pattern of the phased implementation. The cumulative advanced-stage CRC incidence in invitation cohorts invited for screening multiple times was lower than expected based on trends from the pre-screening era. These findings support a causal relationship between the introduction of the Dutch screening programme and a decrease in advanced-stage CRC incidence.

摘要

背景和目的

自 2014 年以来,荷兰基于粪便免疫化学检测的结直肠癌(CRC)筛查计划逐渐按出生队列推出。我们通过邀请时间评估了晚期 CRC 发病率的变化,以进一步加强 CRC 筛查效果的证据。

方法

通过荷兰癌症登记处收集了 2010-2019 年期间邀请队列中晚期 CRC 发病率的数据。计算了晚期 CRC 发病率的粗率和累积晚期 CRC 发病率。通过趋势线外推筛查前的数据,比较了观察到的晚期 CRC 发病率和累积晚期 CRC 发病率与按邀请队列预测的晚期 CRC 发病率和累积晚期 CRC 发病率。

结果

对于 2014 年首次被邀请参加筛查的邀请队列,在筛查引入前的 2010-2013 年期间,晚期 CRC 发病率从 94.1/100,000 人增加到 124.7/100,000 人。2014 年观察到的增长率高于前几年,达到 184.9/100,000 人。此后,发病率下降至低于筛查前趋势预测的水平。在随后的几年中,随着筛查计划的首次邀请,观察到类似的模式。2019 年,所有邀请队列的观察发病率仍然低于预期发病率。2014-2016 年邀请队列的累积晚期 CRC 发病率明显低于 2010-2019 年期间的预期累积 CRC 发病率。

结论

在 2014-2019 年期间,所有首次被邀请参加筛查的邀请队列的晚期 CRC 发病率均有所增加,随后在筛查实施的各个阶段,发病率下降至低于预期水平。多次被邀请参加筛查的邀请队列的累积晚期 CRC 发病率低于基于筛查前时代趋势的预期。这些发现支持荷兰筛查计划的引入与晚期 CRC 发病率下降之间存在因果关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验